Jonathan T. Lord M.D., Director at BIOLASE, INC (BIOL), bought 10,000 shares at $1.36 ($14K) on 2018-11-16, disclosed to the SEC on 2018-11-20.
Open-market purchase of $14k BIOL by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| Filing → |
| BIOL | BUY | 2018-08-14 | $218K | — | Filing → |
| DXCM | SELL | 2016-09-06 | $915K | — | Filing → |
| DXCM | SELL | 2016-08-15 | $906K | — | Filing → |